Methyl 3-[(oxan-4-yl)amino]propanoate, 97%, 250mg

tert-Butyl (2-methyloxazol-4-yl)carbamate, 97%, 10g

2-((2R,3R)-3-(tert-butyl)-4(2,6-dimethoxyphenyl)-2,3dihydrobenzo[d][1,3]oxaphosphol-2-yl)pyridine, 97%, 1g

Ethyl 2-oxo-4-phenylpyrrolidine-3-carboxylate, 95.0%, 250mg

2-Methoxy-4-(methylsulfonyl)-1-nitrobenzene, 95%, 2g

3-Methoxy-3-methyl-1-butanol, min. 99%, for synthesis, 2.5 L, glass packaging

4-(5-Chlorothiazolo[5,4-d]pyrimidin-7-yl)morpholine, 95.0%, 250mg

3,6-Dichloro-2-fluorobenzonitrile, 1g

1-(4-Methoxy-phenyl)-N*1*,N*1*-dimethyl-ethane-1,2-diamine, 95.0%, 1g

2,3,6-Trifluorophenylacetonitrile, 97.0%, 10g

1-(6-Fluoro-[1,1'-biphenyl]-3-yl)ethanone, 98%, 500mg

5- tert -Butyl-2 H -pyrazole-3-carboxylic acid, 95.0%, 1g

Sodium 2-benzamidoacetate, 95+%, 500g